Publications
- Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications2013 | Third Faculty of Medicine, Faculty of Medicine in Pilsen
- Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels2013 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials2013 | Publication without faculty affiliation
- Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice2011 | First Faculty of Medicine
- Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic2010 | Faculty of Physical Education and Sport, Faculty of Medicine in Hradec Králové
- New prognostic markers of chronic lymphocytic leukemia (CLL) in the everyday hematological practice : an analysis of data from four hematology departments2010 | First Faculty of Medicine
- Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia2010 | First Faculty of Medicine
- Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic2010 | First Faculty of Medicine
- Combined molecular biological and molecular cytogenetic analysis of genomic changes in 146 patients with B-cell chronic lymphocytic leukemia2008 | First Faculty of Medicine
- The risk factors analysis in 248 patients with B-cell chronic lymphocytic leukemia at diagnosis2006 | First Faculty of Medicine
Loading network view...